MedPath

Effect of Visceral vs Total Body Fat Reduction in Obese Female With Stress Urinary Incontinence

Not Applicable
Completed
Conditions
Stress Urinary Incontinence
Registration Number
NCT05944484
Lead Sponsor
Dina Mohamed Tarek Mansour El-kasrawy
Brief Summary

The aim of this study is to investigate the visceral fat reduction versus total body fat reduction on stress urinary incontinence in obese females.

Detailed Description

compare the effect of visceral fat reduction versus total body fat reduction on stress urinary incontinence in obese females.

control group: consist of 20 obese women. They will receive Kegel exercises only 3 session/ week for 12 weeks.

Diet group: consist of 20 obese women. They will receive low caloric diet and Kegel exercises 3 session/week for 12 weeks.

Ultrasound cavitation group: consist of 20 obese women. They will receive Kegel exercises 3 session/week and ultrasound cavitation two sessions per week.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • They will be diagnosed with stress urinary incontinence grade≥ 1
  • Their age will range from 35-48 years old.
  • Their body mass index will exceed 29.9 kg/m².
  • Their hip waist ratio will be more than 0.85 cm.
  • They will be multipara >1.
Exclusion Criteria
  • · Fecal incontinence, urge incontinence, overflow incontinence or functional incontinence or prolapse.

    • Diabetes, asthma, cardiovascular, or renal diseases
    • Taking medication for stress urinary incontinence or hormonal replacement therapy.
    • Gynecological surgeries, or surgeries for obesity.
    • Pregnant women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
stress urinary incontinence12 weeks

evaluate stress urinary incontinence by The International Consultation on Incontinence Questionnaire ranged from (0-21)

Question items:

Frequency or urinary incontinence Amount of leakage Overall impact of urinary incontinence Self-diagnostic item. The ICIQ-UI Short form provides a score ranging from 0-21. With a higher score indicating greater severity of symptoms. The "self-diagnostic" portion of the questionnaire is not given a score

Secondary Outcome Measures
NameTimeMethod
waist circumference12 weeks

measure waist circumference in centimeter

Measure weight12 weeks

Measure weight in kilogram

Measure body mass index12 weeks

weight and height will be combined to report BMI in kg/m\^2

Trial Locations

Locations (1)

Faculty of physical therapy

🇪🇬

Cairo, Egypt

Faculty of physical therapy
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.